Telo Genomics Corp.
TELO.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -31.64% | -17.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.56% | -18.19% | |||
| Operating Income | 18.56% | 18.19% | |||
| Income Before Tax | 23.00% | 13.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 23.00% | 13.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.00% | 13.26% | |||
| EBIT | 18.56% | 18.19% | |||
| EBITDA | 18.63% | 18.27% | |||
| EPS Basic | 23.53% | 13.56% | |||
| Normalized Basic EPS | 22.58% | 16.22% | |||
| EPS Diluted | -43.14% | 27.14% | |||
| Normalized Diluted EPS | 22.58% | 16.22% | |||
| Average Basic Shares Outstanding | 0.41% | -0.04% | |||
| Average Diluted Shares Outstanding | 0.41% | -0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||